Associations between lipid-lowering drugs and urate and gout outcomes: a Mendelian randomization study
ObjectiveGout is a common inflammatory arthritis and lipid metabolism plays a crucial role in urate and gout. Potential associations between urate and gout and lipid-lowering drugs have been revealed in observational studies. However, the effects of lipid-lowering drugs on urate and gout remain cont...
Saved in:
Main Authors: | Min Liu, Na Yin, Yuhang Zhu, Aili Du, Chunyuan Cai, Pengyuan Leng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1398023/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mendelian randomization study of serum uric acid levels and urate-lowering drugs on pulmonary arterial hypertension outcomes
by: Xiaoling Yao, et al.
Published: (2025-02-01) -
Insights Into Causal Effects of Genetically Proxied Lipids and Lipid‐Modifying Drug Targets on Cardiometabolic Diseases
by: Liwan Fu, et al.
Published: (2025-02-01) -
Genetic association of lipid-lowering drug target genes with pancreatic cancer: a Mendelian randomization study
by: Bohan Su, et al.
Published: (2025-01-01) -
Lipid-lowering drug targets and lung related diseases: a Mendelian randomization study
by: Haifeng Yu, et al.
Published: (2024-12-01) -
Investigating the role of cathepsins in breast cancer progression: a Mendelian randomization study
by: Shengyi Zhou, et al.
Published: (2025-01-01)